COVID-19 in Space: Possible Health Risks and Preparedness Guidelines

The COVID-19 pandemic resulted in over 705 million infections and 7 million deaths, underscoring the importance of understanding disease behavior across diverse environments. As NASA, SpaceX, and ISRO prepare for more frequent missions, managing health risks for astronauts and space tourists is essential.

This study reviews the literature on airborne infections in space, identifies research gaps, and establishes preparedness strategies for potential COVID-19 outbreaks during space missions.

A systematic literature review was conducted to identify studies examining airborne infectious diseases in space. To compare these findings with Earth-based data, pathogen safety data sheets were used. A separate systematic review was conducted to explore similarities between COVID-19 and the identified airborne infectious diseases. A comparative approach was used to predict COVID-19's potential behavior in microgravity. Existing guidelines for managing airborne diseases in space and on Earth were reviewed and compared to develop a set of preparedness recommendations for COVID-19 in space.

Nine airborne infectious diseases occurring in space were identified. Six tentative effects of COVID-19 in a microgravity environment were theorized in this study. We propose recommendations to improve current space travel health guidelines and address the identified risks.

The results of this study will change the course of human space exploration by assisting in the protection of space travelers and guiding the development of new protocols that include comprehensive safety features.